TCG Crossover GP II, LLC 13D/13G Filings for Cidara Therapeutics, Inc. (CDTX)

TCG Crossover GP II, LLC 13D and 13G filings for Cidara Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-12-03
4:34 pm
Purchase		 2024-11-26 13G Cidara Therapeutics, Inc.
CDTX		 TCG Crossover GP II, LLC 1,005,901
9.200%		 1,005,901increase
(New Position)		 Filing